glp-1 substance use disorder GLP1 receptor agonists are supported by preclinical and observational evidence for reducing addictive behaviors, particularly alcohol and nicotine use. Initial randomized clinical trials indicate possible reductions in craving and intake, though GLP-1s Reduced Risk of Developing

Together, we can help you maximize your results and embrace a healthier, more vibrant future

Many people turn to skin-brightening creams or serums to improve their complexion but these topical solutions often fall short

However, the lower dose of semaglutide used and a focus on patient-reported outcomes rather than on cardiovascular events are limitations of STEP-HFpEF DM

The FDA issued guidance stating that 503A compounding pharmacies had until April 22, 2025 to stop producing semaglutide injection products that were essentially copies of the commercially available drug

amka M, Ruchaa M, Walkowiak J

When it comes to health, especially weight loss with hypothyroidism, it is always recommended to address the foundations first